Literature DB >> 15630364

Gastrostomy tubes in patients with advanced head and neck cancer.

Khwaja Asif Ahmed1, Sandeep Samant, Francisco Vieira.   

Abstract

OBJECTIVES: To measure the percentage of patients requiring gastrostomy tubes (G-tubes) and the timing of their placement, in addition to studying whether pretreatment variables (T stage, tumor site, N stage) and intratreatment variables (weight loss during treatment) are valid predictors for the need for G-tube placement. STUDY
DESIGN: Retrospective case control study.
METHODS: Retrospective review of a prospectively collected database with chart reviews was carried out on 477 patients treated on a regimen of intraarterial cisplatin and concurrent radiation. The likelihood of requiring a G-tube was calculated by studying several independent variables using chi-square analysis and the unpaired t test.
RESULTS: Two hundred twenty (46%) patients had G-tubes placed, with mean time of placement being on day 20 after the initiation of treatment. Patients with T4 disease were statistically more likely to require a G-tube (50% vs. 37%, P < .05). Patients were less likely to require a G-tube when the primary site of tumor involved the larynx or paranasal sinuses (P < .05). There were no statistically significant differences between the two groups with regards to patient age, sex, N stage, and weight changes over the course of treatment. The odds of requiring a G-tube were highest for tumors involving the hypopharynx (80%), oral cavity (52%), and oropharynx (49%).
CONCLUSIONS: Although clinical judgment appears to be sufficient for deciding when G-tube placement is warranted in our population, the threshold for placing a tube should be lower in those patients who had a higher likelihood of requiring a G-tube during the course of treatment, including those with advanced disease of the oral cavity, oropharynx, and hypopharynx.

Entities:  

Mesh:

Year:  2005        PMID: 15630364     DOI: 10.1097/01.mlg.0000150679.60731.bc

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.

Authors:  Molly K Barnhart; Elizabeth C Ward; Bena Cartmill; Rachelle A Robinson; Virginia A Simms; Sophie J Chandler; Elea T Wurth; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-06       Impact factor: 2.503

2.  Safety and long-term outcomes of percutaneous endoscopic gastrostomy in patients with head and neck cancer.

Authors:  Richard E Burney; Benjamin S Bryner
Journal:  Surg Endosc       Date:  2015-03-05       Impact factor: 4.584

3.  Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.

Authors:  Belinda Vangelov; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-26       Impact factor: 2.503

4.  A model for predicting gastrostomy tube placement in patients undergoing surgery for upper aerodigestive tract lesions.

Authors:  Ashley C Mays; Farah Moustafa; Mitch Worley; Joshua D Waltonen; Ralph D'Agostino
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

5.  Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Authors:  Oleksandr Ekshyyan; Youhua Rong; Xiaohua Rong; Kavita M Pattani; Fleurette Abreo; Gloria Caldito; John Kai Siung Chang; Federico Ampil; Jonathan Glass; Cherie-Ann O Nathan
Journal:  Mol Cancer Ther       Date:  2009-07-22       Impact factor: 6.261

6.  The association between gastrostomy tube placement, poor post-operative outcomes, and hospital re-admissions in head and neck cancer patients.

Authors:  Ashley C Mays; Mitchell Worley; Feras Ackall; Ralph D'Agostino; Joshua D Waltonen
Journal:  Surg Oncol       Date:  2015-08-12       Impact factor: 3.279

7.  Patterns of prophylactic gastrostomy tube placement in head and neck cancer patients: a consideration of the significance of social support and practice variation.

Authors:  Julie L Locher; James A Bonner; William R Carroll; Jimmy J Caudell; Jeroan J Allison; Meredith L Kilgore; Christine S Ritchie; Gabriel S Tajeu; Ya Yuan; David L Roth
Journal:  Laryngoscope       Date:  2013-02-07       Impact factor: 3.325

8.  Computed tomography-guided percutaneous gastrostomy: initial experience at a cancer center.

Authors:  Chiang Jeng Tyng; Erich Frank Vater Santos; Luiz Felipe Alves Guerra; Almir Galvão Vieira Bitencourt; Paula Nicole Vieira Pinto Barbosa; Rubens Chojniak
Journal:  Radiol Bras       Date:  2017 Mar-Apr

9.  Rehabilitation approach in oropharyngeal cancer: Case report.

Authors:  Zainab Al Lawati; Riley Smith
Journal:  SAGE Open Med Case Rep       Date:  2021-06-30

10.  Risk of Esophageal Cancer Following Percutaneous Endoscopic Gastrostomy in Head and Neck Cancer Patients: A Nationwide Population-Based Cohort Study in Taiwan.

Authors:  Kuen-Tze Lin; Chun-Shu Lin; Shih-Yu Lee; Wen-Yen Huang; Wei-Kuo Chang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.